Pulmonary arterial hypertension in patients with slow-flow vascular malformations

Archives of Dermatology

Volumn 146, Issue 12, 2010, Pages 1347-1352

  Redondo, Pedro ^a   Rodríguez Mañero, Moisés ^a   Aguado, Leyre ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

D DIMER; FIBRINOGEN; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; ANGIOOSTEOHYPERTROPHY SYNDROME; ARTICLE; BLOOD SAMPLING; BODY SURFACE; CASE CONTROL STUDY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HUMAN; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULMONARY ARTERY; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; SCHOOL CHILD; SYSTOLIC BLOOD PRESSURE; TRANSTHORACIC ECHOCARDIOGRAPHY; VEIN MALFORMATION;

ADOLESCENT; ADULT; BLOOD FLOW VELOCITY; CHILD; CHILD, PRESCHOOL; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, PULMONARY; LYMPHATIC VESSELS; MALE; MIDDLE AGED; PULMONARY WEDGE PRESSURE; RETROSPECTIVE STUDIES; ULTRASONOGRAPHY, DOPPLER; VASCULAR MALFORMATIONS; VEINS; VON WILLEBRAND FACTOR; YOUNG ADULT;

EID: 78650462253     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2010.379     Document Type: Article

References (29)

1. Mulliken JB. Vascular malformations of the head and neck. In: Mulliken JB, Young AE, eds. Vascular Birthmarks: Hemangiomas and Vascular Malformations. Philadelphia, PA: WB Saunders; 1988.
2. Jacob AG, Driscoll DJ, Shaughnessy WJ, Stanson AW, Clay RP, Gloviczki P. Klippel-Trénaunay syndrome: spectrum and management. Mayo Clin Proc. 1998; 73(1):28-36.
3. Mazoyer E, Enjolras O, Bisdorff A, Perdu J, Wassef M, Drouet L. Coagulation disorders in patients with venous malformation of the limbs and trunk: a case series of 118 patients. Arch Dermatol. 2008;144(7):861-867.
4. Enjolras O, Ciabrini D, Mazoyer E, Laurian C, Herbreteau D. Extensive pure venous malformations in the upper or lower limb: a review of 27 cases. J Am Acad Dermatol. 1997;36(2, pt 1):219-225.
5. Mazoyer E, Enjolras O, Laurian C, Houdart E, Drouet L. Coagulation abnormalities associated with extensive venous malformations of the limbs: differentiation from Kasabach-Merritt syndrome. Clin Lab Haematol. 2002;24(4):243-251.
6. Dompmartin A, Acher A, Thibon P, et al. Association of localized intravascular coagulopathy with venous malformations. Arch Dermatol. 2008;144(7):873-877.
7. Dompmartin A, Ballieux F, Thibon P, et al. Elevated D-dimer level in the differential diagnosis of venous malformations. Arch Dermatol. 2009;145(11):1239-1244.
8. Samuel M, Spitz L. Klippel-Trenaunay syndrome: clinical features, complications and management in children. Br J Surg. 1995;82(6):757-761.
9. Baskerville PA, Ackroyd JS, Lea Thomas M, Browse NL. The Klippel-Trenaunay syndrome: clinical, radiological and haemodynamic features and management. Br J Surg. 1985;72(3):232-236.
10. Oduber CE, Gerdes VE, van der Horst CM, Bresser P. Vascular malformations as underlying cause of chronic thromboembolism and pulmonary hypertension. J Plast Reconstr Aesthet Surg. 2009;62(5):684-689.
11. Muluk SC, Ginns LC, Semigran MJ, Kaufman JA, Gertler JP. Klippel-Trénaunay syndrome with multiple pulmonary emboli: an unusual cause of progressive pulmonary dysfunction. J Vasc Surg. 1995;21(4):686-690.
12. Walder B, Kapelanski DP, Auger WR, Fedullo PF. Successful pulmonary thromboendarterectomy in a patient with Klippel-Trenaunay syndrome. Chest. 2000; 117(5):1520-1522.
13. Burbelko M, Kalinowski M, Wagner HJ. Rare cause of chronic recurrent pulmonary emboli and pulmonary artery hypertension [in German]. Dtsch Med Wochenschr. 2006;131(15):811-814.
14. Ulrich S, Fischler M, Walder B, Pfammatter T, Speich R. Klippel-Trenaunay syndrome with small vessel pulmonary arterial hypertension. Thorax. 2005;60 (11):971-973.
15. Gianlupi A, Harper RW, Dwyre DM, Marelich GP. Recurrent pulmonary embolism associated with Klippel-Trenaunay-Weber syndrome. Chest. 1999;115(4):1199-1201.
16. Hein KD, Mulliken JB, Kozakewich HPW, Upton J, Burrows PE. Venous malformations of skeletal muscle. Plast Reconstr Surg. 2002;110(7):1625-1635.
17. Barst RJ, McGoon M, Torbicki A, et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol. 2004;43(12)(suppl S): 40S-47S.
18. Galiè N, Hoeper MM, Humbert M, et al; Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology (ESC); European Respiratory Society (ERS); International Society of Heart and Lung Transplantation (ISHLT). Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. 2009;34(6):1219-1263.
19. Román JS, Hernández FJ, Palma MJ, Medina CO. Diagnosis and treatment of pulmonary hypertension [in Spanish]. Rev Clin Esp. 2008;208(3):142-155.
20. Redondo P. The hidden face of venous malformations: a multidisciplinary therapeutic approach. Arch Dermatol. 2008;144:922-926.
21. Rowbotham BJ, Carroll P, Whitaker AN, et al. Measurement of crosslinked fibrin derivatives: use in the diagnosis of venous thrombosis. Thromb Haemost. 1987; 57(1):59-61.
22. Bounameaux H, de Moerloose P, Perrier A, Reber G. Plasma measurement of D-dimer as diagnostic aid in suspected venous thromboembolism: an overview. Thromb Haemost. 1994;71(1):1-6.
23. Shitrit D, Bendayan D, Rudensky B, et al. Elevation of ELISA D-dimer levels in patients with primary pulmonary hypertension. Respiration. 2002;69(4):327-329. (Pubitemid 34920756)
24. Shitrit D, Bendayan D, Bar-Gil-Shitrit A, et al. Significance of a plasma D-dimer test in patients with primary pulmonary hypertension. Chest. 2002;122(5): 1674-1678. (Pubitemid 35366081)
25. Lopes AA, Caramurú LH, Maeda NY. Endothelial dysfunction associated with chronic intravascular coagulation in secondary pulmonary hypertension. Clin Appl Thromb Hemost. 2002;8(4):353-358.
26. Booth F, Allington MJ, Cederholm-Williams SA. An in vitro model for the study of acute release of von Willebrand factor from human endothelial cells. BrJ Haematol. 1987;67(1):71-78.
27. Paleolog EM, Crossman DC, McVey JH, Pearson JD. Differential regulation by cytokines of constitutive and stimulated secretion of von Willebrand factor from endothelial cells. Blood. 1990;75(3):688-695.
28. Kawut SM, Horn EM, Berekashvili KK, Widlitz AC, Rosenzweig EB, Barst RJ. von Willebrand factor independently predicts long-term survival in patients with pulmonary arterial hypertension. Chest. 2005;128(4):2355-2362.
29. Eddahibi S, Morrell N, d'Ortho MP, Naeije R, Adnot S. Pathobiology of pulmonary arterial hypertension. Eur Respir J. 2002;20(6):1559-1572.